Recent trends in COPD prevalence in Spain: A repeated cross-sectional survey 1997-2007

European Respiratory Journal

Volumn 36, Issue 4, 2010, Pages 758-765

  Soriano, J B ^a   Ancochea, J ^b   Miravitlles, M ^c,g   Garcia Rio F ^d   Duran Tauleria, E ^h,i   Munoz L ^j   Jimenez Ruiz C A ^e   Masa, J F ^c,k   Viejo, J L ^l   Villasante, C ^d   Fernandez Fau L ^b   Sanchez G ^f   Sobradillo Pena V ^m  

^a Recinte Hospital Joan March   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e Comunidad de Madrid ^*  (Spain)

^f GLAXOSMITHKLINE   (Spain)

^g INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^h Institut de Prestacions d'Asistencia Mèdica al Personal Municipal PAMEM   (Spain)

ⁱ HOSPITAL DEL MAR   (Spain)

^j Hospital Universitario Reina Sofia Cordoba   (Argentina)

^k HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^l HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^m HOSPITAL DE CRUCES   (Spain)

more..

Author keywords

Chronic obstructive pulmonary disease; EPI SCAN; IBERPOC; Prevalence; Spain

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SPAIN; SPIROMETRY;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; GEOGRAPHY; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SPAIN;

EID: 77957848006     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00138409     Document Type: Article

References (44)

1. Curry CW, De AK, Ikeda RM, et al. Health burden and funding at the Centers for Disease Control and Prevention. Am J Prev Med 2006; 30: 269-276.
2. Yach D, Hawkes C, Gould CL, et al. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291: 2616-2622.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
4. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
5. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1457.
6. European Respiratory Society/European Lung Foundation. The European Lung White Book: The First Comprehensive Survey on Respiratory Health in Europe. Loddenkemper R, Gibson GJ, Sibille Y, eds. Sheffield, European Respiratory Society Journals, Ltd, 2004.
7. Cifras de población y Censos demográficos. INE 2010. www.ine.es/inebmenu/mnu-cifraspob.htm Last accessed July 2009.
8. Gerez-Valls MD, Velázquez-Valoria I. The health of cities and their citizens (urban development and municipal public health. 2008 SESPAS Report. Gac Sanit 2008; 22: Suppl. 1, 71-78.
9. Soriano JB, Miravitlles M. Datos epidemiologicos en España [Epidemiological data of COPD in Spain]. Arch Bronconeumol 2007; 43: Suppl. 1, 2-9.
10. Comité Científico del Estudio IBERPOC. El proyecto IBERPOC: Un estudio epidemiológico de la EPOC en España [Scientific Committee of the IBERPOC study. The IBERPOC project: an epidemiological study of COPD in Spain]. Arch Bronconeumol 1997; 33: 293-299.
11. Sobradillo-Peña V, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
12. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
13. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
14. Ancochea J, Badiola C, Duran-Tauleria E, et al. The EPI-SCAN Study: A survey to assess the prevalence of chronic obstructive pulmonary disease in 40 to 80 year old in Spain: protocol summary. Arch Bronconeumol 2009; 45: 41-47.
15. Miravitlles M, Soriano JB, Garcia-Rio R, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863-868.
16. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1285-1298.
17. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
18. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
19. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
20. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
21. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
22. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
23. Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD Study. Eur Respir J 2009; 34: 588-597.
24. Burr ML. Epidemiology of childhood asthma. Allerg Immunol (Paris) 1991; 23: 348-350.
25. Pearce N, Sunyer J, Cheng S, et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J 2000; 16: 420-426.
26. Burr ML, Wat D, Evans C, et al. Asthma prevalence in 1973, 1988 and 2003. Thorax 2006; 61: 296-299.
27. Björkstén B, Clayton T, Ellwood P, et al. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19: 110-124.
28. Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130: 1129-1137.
29. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97: 115-122.
30. 1. Eur Respir J 2004; 23: 497-498.
31. Gunawardena KA, Houston K, Smith AP. Evaluation of the turbine pocket spirometer. Thorax 1987; 42: 689-693.
32. Buess CH, Boutellier U, Koller EA. Pneumotachometers. In: Webster JG, ed. Encyclopaedia of Medical Devices and Instrumentation. New York, Wiley, 1988; pp. 2319-2324.
33. Pellegrino R, Brusasco V, Viegi G, et al. Definition of COPD: based on evidence or opinion? Eur Respir J 2008; 31: 681-682.
34. Mannino DM, Buist SA, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007; 62: 237-241.
35. Miller MR, Pedersen OF, Pellegrino R, et al. Debating the definition of airflow obstruction: time to move on? Eur Respir J 2009; 34: 527-528.
36. Spanish National Statistics Institute. www.ine.es Last accessed July 2009.
37. Jiménez-Ruiz C, Miravitlles M, Sobradillo V, et al. Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine Tob Res 2004; 6: 649-653.
38. Barker DJ, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991; 303: 671-675.
39. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006; 82: 485-491.
40. Menezes AM, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007; 30: 1180-1185.
41. Miravitlles M, Ferrer M, Pont A, et al. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 2005; 99: 985-995.
42. Miravitlles M, de la Roza C, Naberan K, et al. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 2007; 101: 1753-1760.
43. Castillo D, Guayta R, Giner J, et al. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot-study. Respir Med 2009; 103: 839-845.
44. Soriano JB, Parkes G. Remember elephants and icebergs... "Your lung function should be in here, but it is there!" Eur Respir J 2009; 33: 715-716.